Viral hemorrhagic fevers;Les fièvres hémorragiques virales

Antibiotiques

Volumn 8, Issue 4, 2006, Pages 215-220

  Zeller, H ^a   Georges Courbot, M C ^a  

^a Institut Pasteur   (France)

Author keywords

Diagnostic; Epidemiology; Hemorrhagic fever; Virus

Indexed keywords

ANTIVIRUS AGENT; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; RIBAVIRIN; VIRUS ANTIGEN; VIRUS VACCINE;

ANTIBODY AFFINITY; ARENAVIRUS; ARTICLE; BAT; BUNYAVIRUS; DENGUE; DIAGNOSTIC PROCEDURE; DRUG EFFICACY; ENZYME LINKED IMMUNOSORBENT ASSAY; FATALITY; FILOVIRIDAE; FLAVIVIRUS; HANTAVIRUS; HOSPITAL INFECTION; HUMAN; MATERNAL MORTALITY; MOSQUITO; NAIRO VIRUS; PATHOPHYSIOLOGY; PATIENT CARE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RISK FACTOR; RODENT; TICK; VIRUS DETECTION; VIRUS GENE; VIRUS HEMORRHAGIC FEVER; VIRUS TRANSMISSION;

EID: 33751565440     PISSN: 12945501     EISSN: None     Source Type: Journal    
DOI: 10.1016/s1294-5501(06)70821-4     Document Type: Article

References (47)

1. GEORGES AJ, GEORGES-COURBOT MC. Fièvres hémorragiques virales : historique et enseignements des quarante dernières années. Med trop 2000 ; 60 : 5-18.
2. HAAS WH, BREUER T, PFAFF G, et al. Imported Lassa fever in Germany : surveillance and management of contact persons. Clin Infect Dis 2003 ; 36 : 1254-8.
3. Anonyme. Imported Lassa fever - New Jersey, 2004. MMWR 2004 ; 53 : 894-7.
4. Anonyme. Management and control of viral haemorrhagic fevers and other highly contagious viral pathogens. European Network for Imported Viral Diseases, 2001 (http://www.enivd.org).
5. GUBLER DJ. The global emergence/resurgence of arboviral diseases as public health problems. Arch Med Res 2002 ; 33 : 330-42.
6. BAE HG, DROSTEN C, EMMERICH P, et al. Analysis of two imported cases of yellow fever infection from Ivory Coast and The Gambia to Germany and Belgium. J Clin Virol 2005 ; 33 : 274-80.
7. CHARREL RN, DE LAMBALLERIE X. Le virus Alkhurma (famille Flaviviridae, genre Flavivirus) : un pathogène émergent responsable de fièvres hémorragiques au Moyen-Orient. Méd trop 2003 ; 63 : 296-9.
8. SHOEMAKER T, BOULIANNE C, VINCENT MJ, et al. Genetic analysis of viruses associated with emergence of Rift valley fever in Saudi Arabia and Yemen. Emerg Infect Dis 2002 ; 8 : 1415-20.
9. SWANEPOEL R, GILL DE, SHEPHERD AJ, et al. The clinical pathology of Crimean-Congo hemorrhagic fever. Rev Infect Dis 1989 ; 11 : S794-800.
10. KARTI SS, ODABASI Z, KORTEN V, et al. Crimean-Congo hemorrhagic fever in Turkey. Emerg Infect Dis 2004 ; 10 : 1379-84.
11. NABETH P, CHEIKH DO, LO B, et al. Crimean-Congo hemorrhagic fever, Mauritania. Emerg Inf Dis 2004 ; 10 : 2143-9.
12. JAURÉGUIBERRY S, TATTEVIN P, TARANTOLA A, et al. Imported Crimean-Congo Hemorrhagic fever J Clin Mircrobiol, 2005 ; 43 : 4905-7.
13. MANTKE OD, SCHMITZ H, ZELLER H, et al. External quality assurance programmes for the diagnostic of imported viral diseases and potential viral agents of bioterrorism to enhance the emergency preparedness in Europe. Eurosurveillance 2005 ; 10 : 6.
14. TESH RB, JAHRLING PB, SALAS R, et al. Description of Guanarito virus (Arenaviridae : Arenavirus), the etiologic agent of Venezuelan GTO. Am J Trop Med Hyg 1994 ; 50 : 452-9.
15. NKOGHE D, FORMENTY P, NNEGUE S, et al. Recommandations pratiques pour la prise en charge sur le terrain des patients infectés par le virus Ebola. Méd trop 2004 ; 64 : 199-204.
16. LEROY EM, KUMULUNGUI B, POURRUT X, et al. Fruit bats as reservoirs of Ebola virus. Nature 2005 ; 438 : 575-6.
17. PETERSON AT, BAUER JT, MILLS JN. Ecologic and geographic distribution of filovirus disease. Emerg Infect Dis 2004 ; 10 : 40-7.
18. STRADY C, JAUSSAUD R, REMY G, et al. Les infections à Hantavirus. Presse Med 2005 ; 34 : 391-9.
19. MAILLES A, ABU SIN M, DUCOFFRE G, et al. Larger than usual increase in cases of hantavirus infections in Belgium, France and Germany, June 2005. Eurosurveillance Weekly 2005 ; 10 : 050721 (http://www.eurosurveillance.org/ew/ 2005/050721.asp#4).
20. YOUNG JC, MILLS JN, ENRIA DA, et al. New World hantaviruses. Br Med Bull, 1998 ; 54 : 659-73.
21. MAHANTY S, BRAY M. Pathogenesis of filoviral haemorrhagic fevers. Lancet Inf Dis 2004 ; 4 : 487-98.
22. BRAY M, GEISBERT TW. Ebola virus : The role of macrophages and dendritic cells in the pathogenesis of Ebola hemorrhagic fever. Int J Biochem Cell Biol 2005 ; 37 : 1560-6.
23. GEISBERT TW, HENSLEY LE. Ebola virus : new insights into disease aetiopathology and possible therapeutic interventions. Expert Rev Mol Med 2004 ; 6 : 1-24.
24. BAIZE S, LEROY EM, GEORGES-COURBOT MC, et al. Defective humoral responses and extensive intravascular apoptosis are associated with fatal outcome in Ebola virus-infected patients. Nat Med 1999 ; 5 : 423-6.
25. BAUSCH DG, DEMBY AH, COULIBALY M, et al. Lassa fever in Guinea : I. Epidemiology of human disease and clinical observations. Vector Borne Zoonotic Dis 2001 ; 1 : 269-81.
26. ZELLER H. Les Fièvres hémorragiques virales : précautions et diagnostic de laboratoire. Rev Fr Lab 2000 ; 321 : 47-50.
27. GUNTHER S, WEISNER B, ROTH A, et al. Lassa fever encephalopathy : Lassa virus in cerebrospinal fluid but not in serum. J Inf Dis 2001 ; 184 : 345-9.
28. BURT FJ, LEMAN PA, SMITH JF, et al. The use of a reverse transcription-polymerase chain reaction for the detection of viral nucleic acid in the diagnosis of Crimean-Congo haemorrhagic fever. J Virol Methods 1998 ; 70 : 129-37.
29. DROSTEN C, KUMMERER BM, SCHMITZ H, et al. Molecular diagnostics of viral hemorrhagic fevers. Antiviral Res 2003 ; 57 : 61-87.
30. JOHNSON BW, RUSSELL BJ, LANCIOTTI RS. Serotype-specific detection of dengue viruses in a fourplex real-time reverse transcriptase PCR assay. J Clin Microbiol 2005 ; 43 : 4977-83.
31. ZAKI A, COUDRIER D, YOUSEF AI, et al. Production of monoclonal antibodies against Rift Valley fever virus. Application for rapid diagnosis tests (virus detection and ELISA) in human sera. J Virol Methods 2006 ; 131 : 34-40.
32. KSIAZEK TG, ROLLIN PE, WILLIAMS AJ, et al. Clinical virology of Ebola hemorrhagic fever (EHF) : virus, virus antigen, and IgG and IgM antibody findings among EHF patients in Kikwit, Democratic Republic of the Congo, 1995. J Inf Dis 1999 ; 179 : S177-87.
33. PAWESKA JT, BURT FJ, SWANEPOEL R. Validation of IgG-sandwich and IgM-capture ELISA for the detection of Rift Valley fever antibodies in humans. J Virol Methods 2005 ; 124 : 173-81.
34. TOWNER JS, ROLLIN PE, BAUSCH DG, et al. Rapid diagnosis of Ebola hemorrhagic fever by reverse transcription-PCR in an outbreak setting and assessment of patient viral load as a predictor of outcome. J Virol 2004 ; 78 : 4330-41.
35. AITICHOU M, SALEH SS, MCELROY AK, et al. Identification of Dobrava, Hantaan, Seoul, and Puumala viruses by one-step real-time RT-PCR J Virol Methods 2005 ; 124 : 21-6.
36. FISHER-HOCH SP, KHAN JA, REHMAN S, et al. Crimean Congo-haemorrhagic fever treated with oral ribavirin. Lancet 1995 ; 346 : 472-5.
37. MCCORMICK JB, KING IJ, WEBB PA, et al. Lassa fever. Effective therapy with ribavirin. N Engl J Med 1986 ; 314 : 20-6.
38. KILGORE PE, KSIAZEK TG, ROLLIN PE, et al. Treatment of Bolivian hemorrhagic fever with intravenous ribavirin. Clin Inf Dis, 1997 ; 24 : 718-22.
39. MONATH TP. Yellow fever vaccine. Expert Rev Vaccines 2005 ; 4 : 553-74.
40. PARK K, KIM CS, MOON KT. Protective effectiveness of hantavirus vaccine. Emerg Infect Dis 2004 ; 10 : 2218-20.
41. BLANEY JE JR, DURBIN AP, MURPHY BR, et al. Development of a live attenuated dengue virus vaccine using reverse genetics. Viral Immunol 2006 ; 19 : 10-32.
42. KITCHENER S, NISSEN M, NASVELD P, et al. Immunogenicity and safety of two live-attenuated tetravalent dengue vaccine formulations in healthy Australian adults. Vaccine 2006 ; 24 : 1238-41.
43. ALAZARD-DANY N, OTTMANN TERRANGLE M, VOLCHKOV V. Ebola et Marburg : les hommes contre-attaquent. Medecine/Sciences 2006 ; 22 : 405-10.
44. Anonyme OMS. Fièvre hémorragique de Marburg. Rel Epid Hebd 2005 ; 80 : 134-138.
45. GEISBERT TW, JONES S, FRITZ EA, et al. Development of a new vaccine for the prevention of Lassa fever. PLoS Med 2005 ; 2 : e183.
46. JONES SM, FELDMANN H, STROHER U, et al. Live attenuated recombinant vaccine protects nonhuman primates against Ebola and Marburg viruses. Nat Med 2005 ; 11 : 786-90.
47. LUKASHEVICH IS, PATTERSON J, CARRION R, et al. A live attenuated vaccine for Lassa Fever made by reassortment of Lassa and Mopeia viruses. J Virol 2005 ; 79 : 13934-42.